Content about Pharmaceutical industry

May 3, 2012
Orphan drugs to see growth through 2018, report finds

Drug makers could strike big with new treatments for rare diseases, according to a new report by a market research firm.

May 2, 2012
FDA approves generic epilepsy drug from Acella

The Food and Drug Administration has approved a generic drug for epilepsy made by Acella Pharmaceuticals, the company said Wednesday.

May 2, 2012
Sandoz acquires Fougera for $1.5 billion

Novartis' generics division has acquired Fougera Pharmaceuticals, the company said Wednesday.

May 1, 2012
Mylan releases generic antimicrobial drug

Generic drug maker Mylan has released a version of a drug used to treat bacterial infections, the company said.

April 27, 2012
FDA approves Novartis drug for tumors in patients with rare genetic disease

A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.

April 26, 2012
FDA declines to approve Takeda diabetes drug

The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.

April 26, 2012
PhRMA report lists almost 300 vaccines under development

Drug makers in the United States are developing nearly 300 vaccines for preventing and treating diseases, according to a new report by a drug industry trade group.

April 25, 2012
Amgen to buy Turkish drug maker for $700 million

Biotech drug maker Amgen is buying a pharmaceutical company based in Turkey, the companies said Wednesday.

April 25, 2012
Sun launches generic version of Zyprexa

Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

April 24, 2012
Dr. Reddy's launches generic version of Zyprexa

Dr. Reddy's Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.

April 24, 2012
FDA outlines global food, drug, device safety strategy

Globalization has led to a rapid increase in the drugs and foods arriving on U.S. shores from abroad, a trend that has prompted U.S. regulators to transform their approach.

April 23, 2012
AstraZeneca buys Ardea Biosciences for $1.26 billion

Anglo-Swedish drug maker AstraZeneca will buy a San Diego-based biotech company for $1.26 billion, the two said Monday.

April 23, 2012
Par buys rights to generic drug for GERD

Par Pharmaceutical has bought rights to a generic drug for gastroesophageal reflux disease from Handa Pharmaceuticals, Par said.

April 23, 2012
Rx for a global safety net

In practical everyday terms, does it matter to the community or health system pharmacist that the Food and Drug Administration is forging ties with other agencies worldwide and becoming more international in its outlook and focus? You bet.

April 23, 2012
Watson launches authorized generic diabetes drug

Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.

April 20, 2012
FDA approves Bayer blood-glucose monitoring system

Regulators have approved a new blood-glucose monitoring system made by Bayer HealthCare, the company said.

April 20, 2012
Generics among fastest-growing industries this decade, report finds

According to the latest numbers, the country's economy is slowly growing, while unemployment has been slowly declining. But while growth has been somewhat less than stellar, 10 industries have outpaced the rest of the economy, including generic drugs.

April 20, 2012
Genzyme to present MS drug trials

Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.

April 19, 2012
GPhA signs on with IMS Health to address drug shortages

A trade organization representing generic drug manufacturers announced Thursday its latest solution to the problem of drug shortages.

April 19, 2012
Watson seeks approval for generic Type 2 diabetes drug

Generic drug maker Watson is challenging the patent protection on a drug used to treat Type 2 diabetes.

April 18, 2012
Valeant buys product lines from Atlantis Pharma for $71 million

Valeant Pharmaceuticals International is acquiring "certain assets" of a drug maker based in Mexico.

April 17, 2012
Mission, EffRx sign agreement for osteoporosis drug

A U.S. drug maker has made a deal with a Swiss company to manufacture and sell a new osteoporosis treatment in North America.

April 16, 2012
Merck, Endocyte sign deal to develop cancer drug

Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.

April 13, 2012
Drug makers invested $49.5 billion in R&D in 2011, report finds

Drug companies invested nearly $50 billion in research and development in 2011, according to a new report by a drug industry trade group.

April 13, 2012
Lilly chief executive John Lechleiter appointed as PhRMA chairman

The Pharmaceutical Research and Manufacturers of America announced Friday the appointment of Eli Lilly chairman, president and CEO John Lechleiter as PhRMA chairman at its annual meeting.

© 2013 Drug Store News. All Rights Reserved.